RIG-I recognizes metabolite-capped RNAs as signaling ligands
Nucleic Acids Research · 25.08.2023 · 51 (15) · 8102-8114
DOI: 10.1093/nar/gkad518 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, online erschienen am 16.06.2023. Verfasst von Brandon D Schweibenz und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Biology, Robert Wood Johnson Medical School, Rutgers University, Piscataway, NJ 08854, USA. Hauptthemen laut MEDLINE: DEAD-box RNA Helicases, RNA, Double-Stranded. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, NIGMS, NIH.
Abstract (Originalsprache)
The innate immune receptor RIG-I recognizes 5′-triphosphate double-stranded RNAs (5′ PPP dsRNA) as pathogenic RNAs. Such RNA-ends are present in viral genomes and replication intermediates, and they activate the RIG-I signaling pathway to produce a potent interferon response essential for viral clearance. Endogenous mRNAs cap the 5′ PPP-end with m7G and methylate the 2′-O-ribose to evade RIG-I, preventing aberrant immune responses deleterious to the cell. Recent studies have identified RNAs in cells capped with metabolites such as NAD+, FAD and dephosphoCoA. Whether RIG-I recognizes these metabolite-capped RNAs has not been investigated. Here, we describe a strategy to make metabolite-capped RNAs free from 5′ PPP dsRNA contamination, using in vitro transcription initiated with metabolites. Mechanistic studies show that metabolite-capped RNAs have a high affinity for RIG-I, stimulating the ATPase activity at comparable levels to 5′ PPP dsRNA. Cellular signaling assays show that the metabolite-capped RNAs potently stimulate the innate antiviral immune response. This demonstrates that RIG-I can tolerate diphosphate-linked, capped RNAs with bulky groups at the 5′ RNA end. This novel class of RNAs that stimulate RIG-I signaling may have cellular roles in activating the interferon response and may be exploited with proper functionalities for RIG-I-related RNA therapeutics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry and Molecular Biology, Robert Wood Johnson Medical School, Rutgers University, Piscataway, NJ 08854, USA.
- Graduate School of Biomedical Sciences at the Robert Wood Johnson Medical School of Rutgers University, USA.
ORCID-Profile: Smita S Patel
Förderung
- NIGMS NIH HHS
- NIGMS
- NIH
Zitieren
APA
Schweibenz, B. D., Solotchi, M., Hanpude, P., Devarkar, S. C., & Patel, S. S. (2023). RIG-I recognizes metabolite-capped RNAs as signaling ligands. Nucleic Acids Research, 51(15), 8102-8114. https://doi.org/10.1093/nar/gkad518
Vancouver
Schweibenz BD, Solotchi M, Hanpude P, Devarkar SC, Patel SS. RIG-I recognizes metabolite-capped RNAs as signaling ligands. Nucleic Acids Research. 2023;51(15):8102-8114. doi:10.1093/nar/gkad518
BibTeX
@article{Schweibenz2023,
author = {Schweibenz, Brandon D and Solotchi, Mihai and Hanpude, Pranita and Devarkar, Swapnil C and Patel, Smita S},
title = {RIG-I recognizes metabolite-capped RNAs as signaling ligands},
journal = {Nucleic Acids Research},
year = {2023},
volume = {51},
number = {15},
pages = {8102--8114},
doi = {10.1093/nar/gkad518}
}
EUVIMED